Low-dose Aspirin Therapy in Patients With Ischemic Stroke and Microbleeds
Status:
Not yet recruiting
Trial end date:
2022-08-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to investigate the safety and efficacy of low-dose (50mg)
aspirin as a secondary prevention drug in patients with Non-Cardioembolic Ischemic Stroke
accompanied by cerebral microbleeds.
Phase:
Phase 4
Details
Lead Sponsor:
Xijing Hospital
Collaborators:
Baoji Central Hospital Shaanxi Provincial People's Hospital Tang-Du Hospital The First Affiliated Hospital of Jiaotong University The First Affiliated Hospital of Xi'an Medical University Xi'an Central Hospital Xiangyang Central Hospital Xianyang Central Hospital